Actions

Atypical patterns of primitive marker expression in acute myeloid leukaemia: Difference between revisions

From haematologyetc.co.uk

No edit summary
No edit summary
Line 30: Line 30:
[[Image:AML M1.png|130px]]   
[[Image:AML M1.png|130px]]   


<span style="font-size:90%">Blast cells with monoblastic differentiation (A) most often express typical patterns of primitive markers. However, where cells undergo more appreciable monocytic differentiation (B) or myelomonocytic differentiation (C) marker patterns may begin to resemble normal or CMML monocytes. Correlation of immunophenotype with morphology and clinical features may be necessary to accurately identify such cells as blasts.''</span>
<span style="font-size:90%">Blast cells with monoblastic differentiation (A) most often express typical patterns of primitive markers. However, where cells undergo more appreciable monocytic differentiation (B) or myelomonocytic differentiation (C) marker patterns may begin to resemble reactive cells or CMML monocytes. Correlation of immunophenotype with morphology and clinical features may be necessary to accurately identify such cells as blasts.''</span>


----
----

Revision as of 12:12, 15 December 2023



Table: Less frequent patterns of primitive phenotype
While blast cells typically cause low side scatter of light and have an expression of CD45 that is lower than normal lymphocytes or monocytes, atypical patterns may be encountered. The more frequent patterns are described below.
AML with monocytic differentiation
In AML with monocytic maturation those primitive cells with more mature monocytic features may show higher side scatter (consistent with their size and cytological features) and some or all of the blast cells may also have high expression of CD45 (comparable with normal or CMML monocytes). Such cases may be difficult to distinguish from typical or transforming CMML. It is important to compare with clinical and morphological features to ensure appropriate classification (See details).
Acute promyelocytic leukaemia
Cells of APL can vary in size and granularity an will often express a range of side scatter features may resemble those of maturing granulocytic cells, similarly CD45 expression may be similar to maturing granulocytic cells. The distribution of cells will be abnormal however and may variably include cells with wide range light scatter features that differ from those of typical blast cells. It is important to distinguish APL blasts from reactive myeloid cells or (in some cases) from cells of MDS. Morphological examination is essential, but consider also the pattern of additional markers (See details).
Other patterns
While most frequently blast cells with myeloid differentiation form a relatively homogenous group with moderately weak CD45 expression, in some cases very weak expression or a wider spread of weak expression my be observed, often more closely resembling appearances of ALL or evn non-haematopoietic tumours.



Blast cells with monocytic differentiation

AML M1.png

Blast cells with monoblastic differentiation (A) most often express typical patterns of primitive markers. However, where cells undergo more appreciable monocytic differentiation (B) or myelomonocytic differentiation (C) marker patterns may begin to resemble reactive cells or CMML monocytes. Correlation of immunophenotype with morphology and clinical features may be necessary to accurately identify such cells as blasts.


Recognition of acute promyelocytic leukaemia

AML M1.png

Typical APL has cells that are hypergranular (A) or microgranular (B) generally with a range of granulation and nuclear appearance (C). While CD45 expression tends to be weak, in almost all cases the variable morphological features cause a wide range of side-scatter with the abnormal cells often forming a "cloud" extending toward the neutrophil area. This can make the cells (particular hypergranular forms) difficult to distinguish from reactive myeloid populations (or occasionally from MDS). Absent HLA-DR on APL cells can help distinguish from reactive cells (expressing HLA-DR), but correlation with morphology and clinical features and other confirmatory tests are essential to the recognition of APL.